#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis Malignant oligodendroglioma Cardiomyopathy Vulval cancer Acute on chronic liver failure Transitional cell cancer of the renal pelvis and ureter Non-renal cell carcinoma of kidney Activated PI3 kinase delta syndrome Craniocerebral injury Drug eruption Primary myelofibrosis Epidermolysis bullosa Pancreatic carcinoma Hereditary ataxia Metabolic disorder More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Trials in Disease Rhabdoid tumour – Diagnostics Usher’s syndrome – Life with Disease Synovial sarcoma recurrent – Diagnostics Breast angiosarcoma – Treatment Propionic acidaemia – Treatment Niemann-Pick disease – Life with Disease Mucopolysaccharidosis I – Diagnostics Haemophilia A with anti factor VIII – Treatment Mucopolysaccharidosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lithium Carbonate Regn7508 Tertomotide Levocetirizine Dihydrochloride Milrinone Zinc Acetate Dihydrate Nemolizumab Ly3473329 Fusidic Acid Bosentan Db-Oto-5 Fexofenadine Hydrochloride Dornase Alfa Seralutinib Asciminib Hydrochloride Pitolisant Balstilimab SULBACTAM SODIUM Futibatinib Efruxifermin More therapies…

    Learn about Your Condition

    Behavioural addiction Non-Hodgkin's lymphoma Albright's disease Complex regional pain syndrome Bronchitis Rectal cancer recurrent Oropharyngeal cancer Lymphocytic leukaemia Chorioretinitis Aphthous ulcer Guttate psoriasis Hypotension Neurofibrosarcoma Mitochondrial DNA depletion Liver disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Melatonin for Patients with Uveal Melanoma to Prevent Metastasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melatonin
    Sweden

  • Study on Preventing Crohn’s Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    • Mirikizumab
    • Risankizumab
    Belgium Italy

  • Study on Dexamethasone and Fluorometholone for Patients Undergoing Corneal Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Corneal graft failure
    • Corneal graft rejection
    Investigated Drugs:
    • Fluorometholone
    • Dexamethasone
    Germany The Netherlands

  • Study on Immunotherapy with Nivolumab and Ipilimumab for Patients with Early Stage dMMR Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Denmark

  • Study on Risankizumab for Children Aged 6-17 With Moderate to Severe Plaque Psoriasis After Completing Previous Study

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Risankizumab
    Germany Poland Spain

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France
Previous Page
1 … 568 569 570 571 572 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!